menu
Insights, News, & Events arrow_right News arrow_right

Morrow Sodali advisor on the Pfizer - Medivation acquisition

30 August 2016 Articles

Morrow Sodali will act as Information Agent in the Pfizer - Medivation M&A deal.

The Companies have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion.

 

Media enquiries

To contact our global experts for comments please get in touch below.

Contact us chevron_right

Subscribe

close

Sign up with your email